|
US4698341A
(en)
|
1983-07-30 |
1987-10-06 |
Godecke Aktiengesellschaft |
Use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis
|
|
JPS62209062A
(ja)
|
1986-03-10 |
1987-09-14 |
Yamanouchi Pharmaceut Co Ltd |
２−ピリジルメチルチオ−または２−ピリジルメチルスルフイニル−置換縮合環化合物
|
|
DE3804990A1
(de)
|
1988-02-18 |
1989-08-31 |
Basf Ag |
Herbizid wirksame, heterocyclisch substituierte sulfonamide
|
|
CA2053148A1
(en)
|
1990-10-16 |
1992-04-17 |
Karnail Atwal |
Dihydropyrimidine derivatives
|
|
WO1993017681A1
(en)
|
1992-03-02 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
WO1993017682A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
JPH0789957A
(ja)
|
1993-09-22 |
1995-04-04 |
Nissan Chem Ind Ltd |
ビフェニルメチルアミン誘導体
|
|
TW263498B
(es)
|
1993-11-10 |
1995-11-21 |
Takeda Pharm Industry Co Ltd |
|
|
DE4344452A1
(de)
|
1993-12-24 |
1995-06-29 |
Hoechst Ag |
Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
ID16283A
(id)
|
1996-03-20 |
1997-09-18 |
Astra Pharma Prod |
Senyawa yang berguna dibidang farmasi
|
|
WO1997047601A1
(en)
|
1996-06-11 |
1997-12-18 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and medicinal uses thereof
|
|
AU727177B2
(en)
|
1996-10-16 |
2000-12-07 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
|
US6177464B1
(en)
|
1997-03-14 |
2001-01-23 |
Sepracor, Inc. |
Ring opening metathesis of alkenes
|
|
US6339099B1
(en)
|
1997-06-20 |
2002-01-15 |
Dupont Pharmaceuticals Company |
Guanidine mimics as factor Xa inhibitors
|
|
DE69939168D1
(de)
|
1998-05-26 |
2008-09-04 |
Warner Lambert Co |
Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung
|
|
AU4429799A
(en)
|
1998-06-12 |
1999-12-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
JP2000123973A
(ja)
|
1998-10-09 |
2000-04-28 |
Canon Inc |
有機発光素子
|
|
DE19900545A1
(de)
|
1999-01-11 |
2000-07-13 |
Basf Ag |
Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
|
|
AU4589800A
(en)
|
1999-05-05 |
2000-11-21 |
Darwin Discovery Limited |
9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7inhibitors
|
|
US6417207B1
(en)
|
1999-05-12 |
2002-07-09 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
|
ES2246922T3
(es)
|
1999-12-28 |
2006-03-01 |
Eisai Co., Ltd. |
Compuestos heterociclicos que tienen grupos de sulfonamida.
|
|
WO2001058899A1
(en)
|
2000-02-09 |
2001-08-16 |
Novartis Ag |
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
|
|
EP1267876A1
(en)
|
2000-03-23 |
2003-01-02 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
EP1294358B1
(en)
|
2000-06-28 |
2004-08-18 |
Smithkline Beecham Plc |
Wet milling process
|
|
JP2004529943A
(ja)
|
2001-05-15 |
2004-09-30 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
殺菌・殺カビ剤としてのピリジニル縮合二環式アミド
|
|
US20030139431A1
(en)
|
2001-09-24 |
2003-07-24 |
Kawakami Joel K. |
Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
|
|
JP2003107641A
(ja)
|
2001-09-27 |
2003-04-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料
|
|
RS63204A
(sr)
|
2002-01-17 |
2006-10-27 |
Neurogen Corporation |
Supstituisani analozi hinazolin-4-ilamina kao modulatori kapsaicina
|
|
WO2003074045A1
(en)
|
2002-03-05 |
2003-09-12 |
Eisai Co., Ltd. |
Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor
|
|
MXPA05001786A
(es)
|
2002-08-13 |
2005-04-25 |
Warner Lambert Co |
Derivados de azaisoquinolina como inhibidores de la metaloproteinasa de matriz.
|
|
ATE404537T1
(de)
|
2002-08-13 |
2008-08-15 |
Shionogi & Co |
Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
|
|
MXPA05003477A
(es)
|
2002-10-03 |
2005-07-22 |
Targegen Inc |
Agentes vasculo-estaticos y metodos de uso de los mismos.
|
|
ES2440217T3
(es)
|
2002-10-04 |
2014-01-28 |
Prana Biotechnology Limited |
Compuestos neurológicamente activos
|
|
AU2003280578A1
(en)
|
2002-10-30 |
2004-05-25 |
Ajinomoto Co., Inc. |
Heterocyclic compounds
|
|
AU2003296984A1
(en)
|
2002-12-13 |
2004-07-09 |
Neurogen Corporation |
2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
|
|
JP2004196702A
(ja)
|
2002-12-18 |
2004-07-15 |
Yamanouchi Pharmaceut Co Ltd |
新規なアミド誘導体又はその塩
|
|
MXPA05009722A
(es)
|
2003-03-10 |
2006-03-09 |
Schering Corp |
Inhibidores heterociclicos de cinasa: metodos de uso y sintesis.
|
|
CA2521619A1
(en)
|
2003-04-11 |
2004-10-28 |
Taigen Biotechnology |
Aminoquinoline compounds
|
|
CA2531327A1
(en)
|
2003-07-03 |
2005-01-13 |
Myriad Genetics, Inc. |
Compounds and therapeutical use thereof
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
CA2533626A1
(en)
|
2003-07-22 |
2005-02-03 |
Janssen Pharmaceutica, N.V. |
Quinolinone derivatives as inhibitors of c-fms kinase
|
|
ATE433974T1
(de)
|
2003-09-19 |
2009-07-15 |
Gilead Sciences Inc |
Azachinolinolphosphonatverbindungen als integraseinhibitoren
|
|
EP1692128A1
(en)
|
2003-11-19 |
2006-08-23 |
Signal Pharmaceuticals LLC |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
|
EP1692112A4
(en)
|
2003-12-08 |
2008-09-24 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS, AND METHODS
|
|
EP1715855A4
(en)
|
2004-01-29 |
2010-06-16 |
Elixir Pharmaceuticals Inc |
ANTIVIRAL DRUGS
|
|
US20050182060A1
(en)
|
2004-02-13 |
2005-08-18 |
Kelly Michael G. |
2-Substituted and 4-substituted aryl nitrone compounds
|
|
GB0403635D0
(en)
|
2004-02-18 |
2004-03-24 |
Devgen Nv |
Pyridinocarboxamides with improved activity as kinase inhibitors
|
|
TW200538120A
(en)
|
2004-02-20 |
2005-12-01 |
Kirin Brewery |
Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same
|
|
WO2005112932A2
(en)
|
2004-05-07 |
2005-12-01 |
Exelixis, Inc. |
Raf modulators and methods of use
|
|
MXPA06013250A
(es)
|
2004-05-14 |
2007-02-28 |
Abbott Lab |
Inhibidores de quinasa como agentes terapeuticos.
|
|
US7569580B2
(en)
|
2004-06-03 |
2009-08-04 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as HCV inhibitors
|
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
|
DE102004041163A1
(de)
|
2004-08-25 |
2006-03-02 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
|
GB0420970D0
(en)
|
2004-09-21 |
2004-10-20 |
Smithkline Beecham Corp |
Novel triazoloquinoline compounds
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
US7846915B2
(en)
|
2004-10-20 |
2010-12-07 |
Resverlogix Corporation |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
FR2877013A1
(fr)
|
2004-10-27 |
2006-04-28 |
Assist Publ Hopitaux De Paris |
Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
|
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
|
CA2592900A1
(en)
|
2005-01-03 |
2006-07-13 |
Myriad Genetics Inc. |
Nitrogen containing bicyclic compounds and therapeutical use thereof
|
|
WO2006072828A2
(en)
|
2005-01-07 |
2006-07-13 |
Pfizer Products Inc. |
Heteroaromatic quinoline compounds and their use as pde10 inhibitors
|
|
EP1865775A1
(en)
|
2005-04-06 |
2007-12-19 |
Irm, Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
|
|
EP2392328A1
(en)
|
2005-05-09 |
2011-12-07 |
Hydra Biosciences, Inc. |
Compounds for modulating TRPV3 Function
|
|
WO2007002781A2
(en)
|
2005-06-28 |
2007-01-04 |
Bausch & Lomb Incorporated |
Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells
|
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ３阻害剤
|
|
CN102127078A
(zh)
|
2005-07-14 |
2011-07-20 |
安斯泰来制药株式会社 |
Janus激酶3的杂环类抑制剂
|
|
WO2007016525A2
(en)
|
2005-07-29 |
2007-02-08 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
EP1917245A1
(de)
|
2005-08-21 |
2008-05-07 |
Abbott GmbH & Co. KG |
Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
|
|
AU2006286576B2
(en)
|
2005-09-01 |
2012-06-14 |
F. Hoffmann-La Roche Ag |
Diaminopyrimidines as P2X3 and P3X2/3 modulators
|
|
US7482360B2
(en)
|
2005-09-23 |
2009-01-27 |
Schering Corporation |
Fused tetracyclic mGluR1 antagonists as therapeutic agents
|
|
WO2007047653A2
(en)
|
2005-10-17 |
2007-04-26 |
Sloan-Kettering Institute For Cancer Research |
Synthetic hla binding peptide analogues of mutant v617f jak2 enzyme and uses therefor
|
|
US20070112015A1
(en)
|
2005-10-28 |
2007-05-17 |
Chemocentryx, Inc. |
Substituted dihydropyridines and methods of use
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
WO2007082131A1
(en)
|
2006-01-09 |
2007-07-19 |
Bristol-Myers Squibb Company |
Process for the preparation of hydroxy substituted heterocycles
|
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2007110868A2
(en)
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
WO2007113565A1
(en)
|
2006-04-06 |
2007-10-11 |
Astrazeneca Ab |
Naphthyridine derivatives as anti-cancer agents
|
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
JP2009536657A
(ja)
|
2006-05-10 |
2009-10-15 |
レノビス， インコーポレイテッド |
イオンチャンネルリガンドとしてのアミド誘導体およびそれを用いる医薬組成物および方法
|
|
JP2009537520A
(ja)
|
2006-05-15 |
2009-10-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｆｇｆ受容体キナーゼ阻害剤のための組成物および方法
|
|
TWI398252B
(zh)
|
2006-05-26 |
2013-06-11 |
諾華公司 |
吡咯并嘧啶化合物及其用途
|
|
JP5415942B2
(ja)
|
2006-06-22 |
2014-02-12 |
プラナ バイオテクノロジー リミティッド |
処置の方法およびその処置に有用な薬剤
|
|
MX2008015768A
(es)
|
2006-06-28 |
2009-01-07 |
Sanofi Aventis |
Nuevos inhibidores de cxcr2.
|
|
CA2655720A1
(en)
|
2006-06-29 |
2008-01-10 |
Schering Corporation |
Substituted bicyclic and tricyclic thrombin receptor antagonists
|
|
SI2041138T1
(sl)
|
2006-07-07 |
2014-08-29 |
Bristol-Myers Squibb Company |
Pirolotriazin kinazni inhibitorji
|
|
GB0614052D0
(en)
|
2006-07-14 |
2006-08-23 |
Amura Therapeutics Ltd |
Compounds
|
|
EP2079724B1
(en)
|
2006-07-20 |
2010-05-26 |
Amgen Inc. |
Substituted pyridone compounds and methods of use
|
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
|
US7531539B2
(en)
|
2006-08-09 |
2009-05-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
RS53263B
(sr)
|
2006-08-14 |
2014-08-29 |
Xencor Inc. |
Optimizovana antitela usmerena na cd19
|
|
JP2010501593A
(ja)
|
2006-08-24 |
2010-01-21 |
セレネックス， インコーポレイテッド |
イソキノリン、キナゾリンおよびフタラジン誘導体
|
|
WO2008046919A2
(en)
|
2006-10-21 |
2008-04-24 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
|
|
KR100789731B1
(ko)
|
2006-11-15 |
2008-01-03 |
전남대학교산학협력단 |
파이로시퀀싱을 이용한 ｊａｋ2 ｖ617ｆ 돌연변이의 정량적검출방법, 시발체 및 키트
|
|
CN101595109B
(zh)
|
2006-11-20 |
2012-09-05 |
百时美施贵宝公司 |
作为二肽基肽酶ⅳ抑制剂的7，8-二氢-1，6-二氮杂萘-5（6h）-酮和相关二环化合物及方法
|
|
ES2415863T3
(es)
|
2006-12-22 |
2013-07-29 |
Incyte Corporation |
Heterociclos sustituidos como inhibidores de Janus Quinasas
|
|
US20100105661A1
(en)
|
2007-01-12 |
2010-04-29 |
Astellas Pharma Inc. |
Condensed pyridine compound
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
AU2008226844A1
(en)
|
2007-03-13 |
2008-09-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
|
|
EP1972627A1
(en)
|
2007-03-19 |
2008-09-24 |
Technische Universität Carolo-Wilhelmina zu Braunschweig |
Amino-napthyridine derivatives
|
|
ES2470341T3
(es)
|
2007-04-05 |
2014-06-23 |
Amgen, Inc |
Moduladores de la aurora cinasa y método de uso
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
|
EP2481735A1
(en)
|
2007-05-09 |
2012-08-01 |
Pfizer Inc. |
Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
|
|
KR20100033981A
(ko)
|
2007-06-03 |
2010-03-31 |
벤더르빌트 유니버시티 |
벤즈아미드 대사성 글루타민산염 수용체5 양성 알로스테릭 조절자 및 이의 제조 및 사용방법
|
|
US9321730B2
(en)
|
2007-08-21 |
2016-04-26 |
The Hong Kong Polytechnic University |
Method of making and administering quinoline derivatives as anti-cancer agents
|
|
US8227639B2
(en)
|
2007-09-26 |
2012-07-24 |
Cardioxyl Pharmaceuticals |
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
|
MY165582A
(en)
|
2008-03-11 |
2018-04-05 |
Incyte Holdings Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
WO2009146034A2
(en)
|
2008-03-31 |
2009-12-03 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
|
WO2010002472A1
(en)
|
2008-07-02 |
2010-01-07 |
Ambit Biosciences Corporation |
Jak kinase modulating compounds and methods of use thereof
|
|
EP2318410A2
(en)
|
2008-07-09 |
2011-05-11 |
Envivo Pharmaceuticals, Inc. |
New small-molecule pde-10 inhibitors
|
|
WO2010026771A1
(ja)
|
2008-09-08 |
2010-03-11 |
日本曹達株式会社 |
含窒素ヘテロ環化合物およびその塩並びに農園芸用殺菌剤
|
|
CA2736258C
(en)
|
2008-09-23 |
2016-11-29 |
Rigel Pharmaceuticals, Inc. |
Tricyclic carbamate jak inhibitors
|
|
US8445676B2
(en)
|
2008-10-08 |
2013-05-21 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
AU2009333251A1
(en)
|
2008-12-16 |
2011-07-07 |
Sirtris Pharmaceuticals, Inc. |
Phthalazinone and related analogs as sirtuin modulators
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
RU2505539C2
(ru)
|
2008-12-23 |
2014-01-27 |
Эбботт Лэборетриз |
Антивирусные соединения
|
|
MX2011007130A
(es)
|
2008-12-29 |
2012-01-20 |
Southern Res Inst |
Compuestos antivirales, tratamiento y dosis.
|
|
CA2754058A1
(en)
|
2009-03-02 |
2010-09-10 |
Sirtris Pharmaceuticals, Inc. |
8-substituted quinolines and related analogs as sirtuin modulators
|
|
JP2012520887A
(ja)
|
2009-03-18 |
2012-09-10 |
シェーリング コーポレイション |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
|
|
NZ617779A
(en)
|
2009-03-18 |
2015-08-28 |
Resverlogix Corp |
Novel anti-inflammatory agents
|
|
US8691187B2
(en)
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
|
CN102438660A
(zh)
|
2009-03-23 |
2012-05-02 |
美国西门子医疗解决公司 |
用于检测神经障碍的显像剂
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン， エルエルシー |
複素環式化合物およびその使用
|
|
WO2010141062A1
(en)
|
2009-06-04 |
2010-12-09 |
Ludwig Institute For Cancer Research Ltd. |
Inhibitors of constitutively active janus kinases and uses thereof
|
|
US10253020B2
(en)
|
2009-06-12 |
2019-04-09 |
Abivax |
Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
|
|
CN102625804B
(zh)
|
2009-06-12 |
2015-04-08 |
Abivax公司 |
用于治疗aids的化合物
|
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
UA111579C2
(uk)
|
2009-08-17 |
2016-05-25 |
Інтеллікіне Ллк |
ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
|
|
SI2473510T1
(sl)
|
2009-09-03 |
2014-10-30 |
Bristol-Myers Squibb Company |
Jak2 inhibitorji in njihova uporaba za zdravljenje mieloproliferativnih bolezni in raka
|
|
KR101097315B1
(ko)
|
2009-10-12 |
2011-12-23 |
삼성모바일디스플레이주식회사 |
유기 발광 소자
|
|
EP2947073B1
(en)
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
JP5993742B2
(ja)
|
2009-10-29 |
2016-09-14 |
ジェノスコ |
キナーゼ阻害剤
|
|
JP2013512282A
(ja)
|
2009-12-01 |
2013-04-11 |
アボット・ラボラトリーズ |
新規三環式化合物
|
|
JP5848712B2
(ja)
|
2009-12-11 |
2016-01-27 |
ノノ インコーポレイテッド |
虚血性疾患および他の疾患を治療するための薬剤および方法
|
|
WO2011075630A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
|
US20130029978A1
(en)
|
2009-12-25 |
2013-01-31 |
Mochida Pharmaceutical Co., Ltd. |
Novel aryl urea derivative
|
|
CN102712640A
(zh)
|
2010-01-12 |
2012-10-03 |
弗·哈夫曼-拉罗切有限公司 |
三环杂环化合物、其组合物和应用方法
|
|
CA2789344A1
(en)
|
2010-02-15 |
2011-08-18 |
Jeremy Earle Wulff |
Synthesis of bicyclic compounds and method for their use as therapeutic agents
|
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
|
WO2011112687A2
(en)
|
2010-03-10 |
2011-09-15 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
ES2753523T3
(es)
|
2010-04-02 |
2020-04-13 |
Firmenich Incorporated |
Modificador del sabor dulce
|
|
US20130109687A1
(en)
|
2010-04-30 |
2013-05-02 |
Gary J. Nabel |
Methods of treating hiv infection: inhibition of dna dependent protein kinase
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
EP3034509B1
(en)
|
2010-10-26 |
2020-04-22 |
Mars, Incorporated |
Arginase inhibitors as therapeutics
|
|
US20140031355A1
(en)
|
2010-11-04 |
2014-01-30 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
EP2640392B1
(en)
|
2010-11-18 |
2015-01-07 |
Kasina Laila Innova Pharmaceuticals Private Ltd. |
Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
|
|
WO2012078902A2
(en)
|
2010-12-08 |
2012-06-14 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators
|
|
WO2012083866A1
(en)
|
2010-12-22 |
2012-06-28 |
The Hong Kong Polytechnic University |
Quinoline derivatives as anti-cancer agents
|
|
WO2012085176A1
(en)
|
2010-12-23 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
|
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
WO2012097479A1
(en)
|
2011-01-21 |
2012-07-26 |
Abbott Laboratories |
Bicyclic inhibitors of anaphastic lymphoma kinase
|
|
US20120214842A1
(en)
|
2011-02-18 |
2012-08-23 |
Exonhit Therapeutics Sa |
Methods for treating diseases of the retina
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
AU2012232658B2
(en)
|
2011-03-22 |
2016-06-09 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
US9433219B2
(en)
|
2011-04-20 |
2016-09-06 |
The Regents Of The University Of California |
Fungi antagonistic to xylella fastidiosa
|
|
CN102838601A
(zh)
|
2011-06-24 |
2012-12-26 |
山东亨利医药科技有限责任公司 |
选择性磷酰肌醇3-激酶δ抑制剂
|
|
CN102838600A
(zh)
|
2011-06-24 |
2012-12-26 |
山东亨利医药科技有限责任公司 |
苯基喹唑啉类PI3Kδ抑制剂
|
|
WO2013007765A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Fused tricyclic compounds for use as inhibitors of janus kinases
|
|
WO2013033093A1
(en)
|
2011-08-29 |
2013-03-07 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
|
PE20141371A1
(es)
|
2011-08-29 |
2014-10-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
|
JP2014528410A
(ja)
|
2011-09-30 |
2014-10-27 |
キネタ・インコーポレイテツド |
抗ウイルス化合物
|
|
WO2013062987A1
(en)
|
2011-10-24 |
2013-05-02 |
New York University |
Methods for identifying janus kinase (jak) modulators for therapeutics
|
|
US20140256767A1
(en)
|
2011-10-31 |
2014-09-11 |
The Broad Institute, Inc. |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
|
WO2013086229A1
(en)
|
2011-12-07 |
2013-06-13 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
AU2013258027B2
(en)
|
2012-05-08 |
2017-11-30 |
Merck & Cie |
18F-labelled follate/antifolate analogues
|
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
BR112015001613B1
(pt)
|
2012-07-27 |
2021-02-23 |
Biogen Ma Inc |
compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx, seus usos e composição farmacêutica
|
|
WO2014023377A2
(de)
|
2012-08-07 |
2014-02-13 |
Merck Patent Gmbh |
Metallkomplexe
|
|
EP2900639B1
(en)
|
2012-09-27 |
2017-08-16 |
Portola Pharmaceuticals, Inc. |
Bicyclic dihydropyridone kinase inhibitors
|
|
FR2996129B1
(fr)
|
2012-09-28 |
2014-12-19 |
Oreal |
Procede de coloration capillaire mettant en oeuvre au moins un derive d'heterocycle azote, un sel de manganese ou de zinc, du peroxyde d'hydrogene et du (bi)carbonate
|
|
AU2013341271A1
(en)
|
2012-11-07 |
2015-05-14 |
Novartis Ag |
Combination therapy
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
WO2014087165A1
(en)
|
2012-12-06 |
2014-06-12 |
University Of Bath |
Tankyrase inhibitors
|
|
CA2899322A1
(en)
|
2013-01-29 |
2014-08-07 |
Biogen Ma Inc. |
S1p modulating agents
|
|
KR102081281B1
(ko)
|
2013-02-08 |
2020-05-28 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
|
KR102147424B1
(ko)
|
2013-03-08 |
2020-08-25 |
에스에프씨 주식회사 |
유기발광 화합물 및 이를 포함하는 유기전계발광소자
|
|
US9333213B2
(en)
|
2013-03-15 |
2016-05-10 |
Duke University |
Prochelators as broad-spectrum antimicrobial agents and methods of use
|
|
JP2016522247A
(ja)
|
2013-06-18 |
2016-07-28 |
ノバルティス アーゲー |
組合せ医薬
|
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
|
KR101682020B1
(ko)
|
2013-06-28 |
2016-12-02 |
제일모직 주식회사 |
화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
|
|
CA2916623C
(en)
|
2013-07-05 |
2021-09-14 |
Abivax |
Bicyclic compounds useful for treating diseases caused by retroviruses
|
|
TW201542538A
(zh)
|
2013-07-16 |
2015-11-16 |
奇尼塔公司 |
抗病毒化合物、醫藥組合物及其使用方法
|
|
KR20160043118A
(ko)
|
2013-08-21 |
2016-04-20 |
리스버로직스 코퍼레이션 |
가속화된 경화반 퇴행을 위한 조성물 및 치료방법
|
|
AR097631A1
(es)
|
2013-09-16 |
2016-04-06 |
Bayer Pharma AG |
Trifluorometilpirimidinonas sustituidas con heterociclos y sus usos
|
|
US10407394B2
(en)
|
2013-10-04 |
2019-09-10 |
Merck Patent Gmbh |
Triarylamine-substituted benzo[H]quinoline-derivatives as materials for electronic devices
|
|
US9815797B2
(en)
|
2013-12-09 |
2017-11-14 |
Ucb Biopharma Sprl |
Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
|
|
CN104725249B
(zh)
|
2013-12-20 |
2019-02-12 |
广东东阳光药业有限公司 |
苄胺类衍生物及其在药物上的应用
|
|
CN104860931A
(zh)
|
2014-02-21 |
2015-08-26 |
常州寅盛药业有限公司 |
丙肝病毒抑制剂及其制药用途
|
|
JP6377245B2
(ja)
|
2014-03-24 |
2018-08-22 |
グアンドン ジョンシェン ファーマシューティカル カンパニー リミテッド |
Ｓｍｏ阻害剤としてのキノリン誘導体
|
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
|
US9902702B2
(en)
|
2014-07-15 |
2018-02-27 |
Bristol-Myers Squibb Company |
Spirocycloheptanes as inhibitors of rock
|
|
JP2017522324A
(ja)
|
2014-07-17 |
2017-08-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
新規ナフチリジン及びイソキノリンならびにｃｄｋ８／１９阻害剤としてのその使用
|
|
CN105461714B
(zh)
|
2014-09-29 |
2017-11-28 |
山东轩竹医药科技有限公司 |
并环类pi3k抑制剂
|
|
KR102308118B1
(ko)
|
2014-10-22 |
2021-10-01 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
CN104311426A
(zh)
|
2014-10-27 |
2015-01-28 |
厦门大学 |
芳香硝基乙烯化合物的新用途
|
|
CN105732591B
(zh)
|
2014-12-31 |
2019-10-25 |
广东东阳光药业有限公司 |
取代的哌嗪化合物及其使用方法和用途
|
|
EP3247692B1
(en)
|
2015-01-23 |
2022-09-07 |
GVK Biosciences Private Limited |
Inhibitors of trka kinase
|
|
US10227343B2
(en)
|
2015-01-30 |
2019-03-12 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
|
CA2974874A1
(en)
|
2015-02-11 |
2016-08-18 |
Basilea Pharmaceutica International AG |
Substituted mono- and polyazanaphthalene derivatives and their use
|
|
EP3059591A1
(en)
|
2015-02-23 |
2016-08-24 |
Abivax |
Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
|
|
EP3277293A4
(en)
|
2015-03-30 |
2019-01-16 |
Jeffrey Thomas Loh |
PROCESS FOR IN VITRO PRODUCTION OF BLOOD PLATES AND COMPOSITIONS AND USES THEREOF
|
|
CN105481765A
(zh)
|
2015-04-15 |
2016-04-13 |
江苏艾凡生物医药有限公司 |
一类用于治疗心力衰竭的酰腙类衍生物
|
|
KR101904300B1
(ko)
|
2015-04-15 |
2018-10-04 |
삼성에스디아이 주식회사 |
유기 광전자 소자용 화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
|
|
WO2016190847A1
(en)
|
2015-05-26 |
2016-12-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
WO2016197027A1
(en)
|
2015-06-04 |
2016-12-08 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
PE20180572A1
(es)
|
2015-06-18 |
2018-04-04 |
Cephalon Inc |
Derivados de piperidina 1,4-sustituidos
|
|
BR112017027951A2
(pt)
|
2015-06-22 |
2018-08-28 |
Ono Pharmaceutical Co., Ltd. |
composto inibitório de brk
|
|
WO2017004134A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
KR102192691B1
(ko)
|
2015-06-30 |
2020-12-17 |
(주)피엔에이치테크 |
유기발광 화합물 및 이를 포함하는 유기전계발광소자
|
|
US9957267B2
(en)
|
2015-07-01 |
2018-05-01 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
|
CN107922409A
(zh)
|
2015-08-17 |
2018-04-17 |
鲁宾有限公司 |
作为parp抑制剂的杂芳基衍生物
|
|
MA43037A
(fr)
|
2015-10-02 |
2018-08-08 |
Dana Farber Cancer Inst Inc |
Polythérapie par inhibiteurs de bromodomaine et blocage de point de contrôle
|
|
US20170107216A1
(en)
|
2015-10-19 |
2017-04-20 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CN108430986B
(zh)
|
2015-10-26 |
2021-08-31 |
拜耳作物科学股份公司 |
作为有害生物控制剂的稠合双环杂环衍生物
|
|
SG11201803242TA
(en)
|
2015-10-29 |
2018-05-30 |
Effector Therapeutics Inc |
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of mnk1 and mnk2
|
|
AR106515A1
(es)
|
2015-10-29 |
2018-01-24 |
Bayer Cropscience Ag |
Sililfenoxiheterociclos trisustituidos y análogos
|
|
DK3368541T3
(da)
|
2015-10-30 |
2020-06-29 |
Calithera Biosciences Inc |
Sammensætninger og metoder til inhibiering af arginaseaktivitet
|
|
MD3377488T2
(ro)
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
WO2017090002A2
(en)
|
2015-11-27 |
2017-06-01 |
Gvk Biosciences Private Limited |
Inhibitors of pi3 kinases
|
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
|
US10646465B2
(en)
|
2015-12-17 |
2020-05-12 |
Biokine Therapeutics Ltd. |
Small molecules against cancer
|
|
CA3009474A1
(en)
|
2015-12-22 |
2017-06-29 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
AU2017252276A1
(en)
|
2016-04-18 |
2018-11-15 |
Celgene Quanticel Research, Inc. |
Therapeutic compounds
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
MA45146A
(fr)
|
2016-05-24 |
2021-03-24 |
Constellation Pharmaceuticals Inc |
Dérivés de pyrazolopyridine pour le traitement du cancer
|
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SG11201811414TA
(en)
|
2016-06-20 |
2019-01-30 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
US11285218B2
(en)
|
2016-06-23 |
2022-03-29 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use
|
|
EP3481816B1
(en)
|
2016-07-07 |
2020-06-24 |
Bristol-Myers Squibb Company |
Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
GB201615282D0
(en)
|
2016-09-08 |
2016-10-26 |
Univ Bath |
Tankyrase inhibitors
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
US10377743B2
(en)
|
2016-10-07 |
2019-08-13 |
Araxes Pharma Llc |
Inhibitors of RAS and methods of use thereof
|
|
KR20190070972A
(ko)
|
2016-11-02 |
2019-06-21 |
얀센 파마슈티카 엔.브이. |
Pde2 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리미딘 유도체
|
|
JOP20190144A1
(ar)
*
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
WO2018119440A1
(en)
|
2016-12-22 |
2018-06-28 |
Calithera Biosciences, Inc. |
Compositions and methods for inhibiting arginase activity
|
|
JP7327802B2
(ja)
|
2017-01-26 |
2023-08-16 |
アラクセス ファーマ エルエルシー |
縮合ヘテロ－ヘテロ二環式化合物およびその使用方法
|
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
US20200000099A1
(en)
|
2017-01-31 |
2020-01-02 |
The Regents Of The University Of California |
Organisms antagonistic to xylella fastidiosa
|
|
US11066420B2
(en)
|
2017-05-01 |
2021-07-20 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
|
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
|
EP3630836A1
(en)
|
2017-05-31 |
2020-04-08 |
Elstar Therapeutics, Inc. |
Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
|
|
CN110831593A
(zh)
|
2017-06-14 |
2020-02-21 |
特维娜有限公司 |
用于调节s1p1活性的化合物及其使用方法
|
|
WO2018237370A1
(en)
|
2017-06-23 |
2018-12-27 |
Accro Bioscience Inc. |
Heteroaryl compounds as inhibitors of necrosis, composition and method using the same
|
|
KR102678977B1
(ko)
|
2017-09-25 |
2024-06-28 |
씨젠테크 (쑤저우, 차이나) 컴퍼니 리미티드 |
Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법
|
|
GEAP202215303A
(en)
|
2017-10-02 |
2022-04-11 |
Merck Sharp & Dohme |
Chromane monobactam compounds for the treatment of bacterial infections
|
|
CN109575022B
(zh)
|
2017-12-25 |
2021-09-21 |
成都海博锐药业有限公司 |
一种化合物及其用途
|
|
CN109608504B
(zh)
|
2017-12-28 |
2022-04-05 |
广州华睿光电材料有限公司 |
有机金属配合物、聚合物、混合物、组合物和有机电子器件
|
|
CN109988109B
(zh)
|
2017-12-29 |
2020-12-29 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其用途
|
|
EP3735242A4
(en)
|
2018-01-03 |
2021-09-01 |
Merck Sharp & Dohme Corp. |
METALLO-BETA-LACTAMASE INHIBITORS AND METHOD OF USING THEREOF
|
|
EP3578555B1
(en)
|
2018-01-16 |
2022-09-21 |
Shenzhen TargetRx, Inc. |
Diphenylaminopyrimidine compound for inhibiting kinase activity
|
|
US12012394B2
(en)
|
2018-02-19 |
2024-06-18 |
Washington University |
Alpha-synuclein ligands
|
|
US11691967B2
(en)
|
2018-03-12 |
2023-07-04 |
The Board Of Trustees Of The University Of Illinois |
Antibiotics effective for gram-negative pathogens
|
|
WO2019201283A1
(en)
|
2018-04-20 |
2019-10-24 |
Xrad Therapeutics, Inc. |
Dual atm and dna-pk inhibitors for use in anti-tumor therapy
|
|
RS66310B1
(sr)
|
2018-05-04 |
2025-01-31 |
Incyte Corp |
Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
|
|
CN111836814B
(zh)
|
2018-05-11 |
2023-10-20 |
四川科伦博泰生物医药股份有限公司 |
稠环化合物、其制备方法及用途
|
|
CN111484480B
(zh)
|
2019-01-29 |
2023-08-11 |
上海翰森生物医药科技有限公司 |
一种多环类衍生物抑制剂、其制备方法和应用
|
|
WO2020200291A1
(en)
|
2019-04-02 |
2020-10-08 |
Cullgen (Shanghai) , Inc. |
Compounds and methods of treating cancers
|
|
CN112300180B
(zh)
|
2019-07-26 |
2022-04-29 |
珠海宇繁生物科技有限责任公司 |
一种irak4激酶抑制剂及其制备方法
|
|
WO2021257857A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Naphthyridinone compounds as jak2 v617f inhibitors
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
IL299612A
(en)
|
2020-07-02 |
2023-03-01 |
Incyte Corp |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
CA3192868A1
(en)
|
2020-09-24 |
2022-03-31 |
Auckland Uniservices Limited |
Novel aminopyridines and their use in treating cancer
|
|
WO2022133285A1
(en)
|
2020-12-18 |
2022-06-23 |
St. Jude Children's Research Hospital |
Molecules and methods related to treatmnet of disorders associated with jak-2 signaling dysfunction
|
|
US11919908B2
(en)
|
2020-12-21 |
2024-03-05 |
Incyte Corporation |
Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
|
|
CA3211748A1
(en)
|
2021-02-25 |
2022-09-01 |
Incyte Corporation |
Spirocyclic lactams as jak2 v617f inhibitors
|
|
US20240300977A1
(en)
|
2021-04-17 |
2024-09-12 |
Intellia Therapeutics, Inc. |
Inhibitors of dna-dependent protein kinase and compositions and uses thereof
|
|
WO2023036156A1
(zh)
|
2021-09-07 |
2023-03-16 |
首药控股(北京)股份有限公司 |
Dna-pk选择性抑制剂及其制备方法和用途
|
|
WO2023155905A1
(zh)
|
2022-02-21 |
2023-08-24 |
上海岸阔医药科技有限公司 |
化合物及其用途
|
|
IL315647A
(en)
|
2022-03-17 |
2024-11-01 |
Incyte Corp |
Tricyclic urea compounds as Jak2 and 617f inhibitors
|
|
WO2024086273A1
(en)
|
2022-10-21 |
2024-04-25 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|